Search research articles
Contact Us
Filters
Showing results (1191-1200 of 1,226) with videos related to
Page
of 123
Sort By:
Antiviral Therapy
|
February 15, 2013
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial
Robert A Ogert, John A Howe, John M Vierling, et al.
Cell Host & Microbe
|
January 3, 2023
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy
Xiaodong Lian, Kyra W Seiger, Elizabeth M Parsons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 8, 2024
Mpox in People With Human Immunodeficiency Virus: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite Cohort
Michalina Montaño, Adrienne E Shapiro, Bridget M Whitney, et al.
AIDS Research and Human Retroviruses
|
February 1, 2007
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1
Tong-Ming Fu, Sheri A Dubey, Devan V Mehrotra, et al.
The American Journal of Gastroenterology
|
November 11, 2005
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C
Ira M Jacobson, Stevan A Gonzalez, Furqaan Ahmed, et al.
Journal of Hepatology
|
July 28, 2014
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J Muir, Sanjeev Arora, Gregory Everson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 6, 2023
HIV post-treatment controllers have distinct immunological and virological features
Behzad Etemad, Xiaoming Sun, Yijia Li, et al.
Emerging Microbes & Infections
|
March 6, 2024
Effective and targeted latency reversal in CD4<sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection
Minh Ha Ngo, Joshua Pankrac, Ryan C Y Ho, et al.
Science Translational Medicine
|
September 17, 2025
Sex differences in HIV-1 reservoir cell selection are linked to altered innate immune profiles
Toong Seng Tan, Ce Gao, Alexander S Hochroth, et al.
Open Forum Infectious Diseases
|
August 11, 2021
Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)
Lisa R Metsch, Daniel J Feaster, Lauren K Gooden, et al.
Page
of 123
Search research articles
Search
Showing results (1191-1200 of 1,226) with videos related to
Sort By:
Page
of 123
Antiviral Therapy
|
February 15, 2013
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial
Robert A Ogert, John A Howe, John M Vierling, et al.
Cell Host & Microbe
|
January 3, 2023
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy
Xiaodong Lian, Kyra W Seiger, Elizabeth M Parsons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 8, 2024
Mpox in People With Human Immunodeficiency Virus: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite Cohort
Michalina Montaño, Adrienne E Shapiro, Bridget M Whitney, et al.
AIDS Research and Human Retroviruses
|
February 1, 2007
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1
Tong-Ming Fu, Sheri A Dubey, Devan V Mehrotra, et al.
The American Journal of Gastroenterology
|
November 11, 2005
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C
Ira M Jacobson, Stevan A Gonzalez, Furqaan Ahmed, et al.
Journal of Hepatology
|
July 28, 2014
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J Muir, Sanjeev Arora, Gregory Everson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 6, 2023
HIV post-treatment controllers have distinct immunological and virological features
Behzad Etemad, Xiaoming Sun, Yijia Li, et al.
Emerging Microbes & Infections
|
March 6, 2024
Effective and targeted latency reversal in CD4<sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection
Minh Ha Ngo, Joshua Pankrac, Ryan C Y Ho, et al.
Science Translational Medicine
|
September 17, 2025
Sex differences in HIV-1 reservoir cell selection are linked to altered innate immune profiles
Toong Seng Tan, Ce Gao, Alexander S Hochroth, et al.
Open Forum Infectious Diseases
|
August 11, 2021
Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)
Lisa R Metsch, Daniel J Feaster, Lauren K Gooden, et al.
Page
of 123